IWMPD
PGNX

Integrated Wealth Management (Palm Desert)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-166
Closed -$1K – 1348
2016
Q2 		$1K Hold
166
– – ﹤0.01% 1239
2016
Q1 		$1K Hold
166
– – ﹤0.01% 1161
2015
Q4 		$1K Hold
166
– – ﹤0.01% 1260
2015
Q3 		$1K Hold
166
– – ﹤0.01% 1266
2015
Q2 		$1K Buy
+166
New +$1K ﹤0.01% 1304

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s PGNX Position: Q3 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2016, closing a stake of 166 shares — an estimated $1K sold.

Integrated Wealth Management (Palm Desert) first reported a position in PGNX in Q2 2015 and held it in 5 quarters. The position peaked at $1K in Q2 2016. 115 funds tracked by Wall St. Rank hold PGNX as of Q3 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 166 Progenics Pharmaceuticals Inc shares in Q3 2016, an estimated $1K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Progenics Pharmaceuticals Inc in Q2 2015 and held it in 5 quarters.
  • Integrated Wealth Management (Palm Desert)'s Progenics Pharmaceuticals Inc position peaked at $1K in Q2 2016.
  • 115 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q3 2016, filed 21 Oct 2016.